Glenmark Pharmaceuticals

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue3,4193,2683,2916,2483,945
Expenses2,9622,8872,8723,8953,227
EBITDA631.36572.72606.972,560914.22
EBIT508.6274.68153.811,034575.43
Profit Before Tax456.337.9795.58967.40534.00
Net Profit348.034.3846.97610.43403.23
Financial Ratios
Operating Profit Margin19.12%6.21%9.27%19.57%18.77%
Net Profit Margin10.54%11.50%8.52%25.57%13.89%
Earning Per Share (Diluted)12.330.161.6621.6214.28
Dividends Per Share0.000.000.000.000.00